Organogenesis
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 862
- Market Cap
- -
- Introduction
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
A Pilot Study of CelTx(TM) (Apligraf®) in the Treatment of Gingival Recession Requiring Root Coverage
- Conditions
- Gingival Recession
- Interventions
- Device: CelTxOther: Autologous sub-epithelial connective tissue graft
- First Posted Date
- 2008-05-16
- Last Posted Date
- 2012-01-11
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 15
- Registration Number
- NCT00679081
- Locations
- 🇺🇸
Perio Health Professionals, PLLC, Houston, Texas, United States
A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers
- Conditions
- Varicose Ulcer
- Interventions
- Device: Apligraf
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2015-08-19
- Lead Sponsor
- Organogenesis
- Registration Number
- NCT00648674
Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)
- Conditions
- Epidermolysis Bullosa, JunctionalEpidermolysis Bullosa Dystrophica
- Interventions
- Device: ApligrafOther: Standard dressing regimen
- First Posted Date
- 2008-01-07
- Last Posted Date
- 2010-06-29
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 1
- Registration Number
- NCT00587223
- Locations
- 🇺🇸
University of Miami - Miller School of Medicine, Miami, Florida, United States
🇺🇸University of Texas, Houston, Texas, United States
🇺🇸Children's Hospital of Cincinnati, Cincinnati, Ohio, United States
Safety and Efficacy of Gintuit(TM)for Oral Soft Tissue Regeneration
- Conditions
- Gingival Recession
- Interventions
- Device: GintuitOther: Autologous palatal tissue
- First Posted Date
- 2008-01-07
- Last Posted Date
- 2012-11-08
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 96
- Registration Number
- NCT00587834
- Locations
- 🇺🇸
Nevins Perio, LLC, Boston, Massachusetts, United States
🇺🇸Perio Health Professionals, PLLC, Houston, Texas, United States
🇺🇸Michigan Center for Oral Health Research, Ann Arbor, Michigan, United States
A Pilot Study of Apligraf for the Treatment and Prevention of Recurrence of Excised Keloids
- Conditions
- Keloid
- Interventions
- Device: ApligrafOther: Standard dressing regimen
- First Posted Date
- 2008-01-07
- Last Posted Date
- 2011-08-19
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 30
- Registration Number
- NCT00587587
- Locations
- 🇺🇸
University of Miami, Miller School of Medicine, Division of Cosmetic Dermatology, Miami Beach, Florida, United States
Apligraf Versus Standard Therapy in the Treatment of Diabetic Foot Ulcers
- Conditions
- Diabetic Foot
- First Posted Date
- 2007-08-07
- Last Posted Date
- 2007-08-07
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 82
- Registration Number
- NCT00512538